Cipla Ltd CIPLA-IN:National Stock Exchange of India

*Data is delayed | INR
Last | 3:29 PM IST
898.60quote price arrow up+7.70 (+0.86%)
Volume
5,224,240
52 week range
565.60 - 966.35

...

Loading . . .
  • Open889.30
  • Day High906.75
  • Day Low884.30
  • Prev Close890.90
  • 52 Week High966.35
  • 52 Week High Date04/20/21
  • 52 Week Low565.60
  • 52 Week Low Date05/15/20

Key Stats

  • Market Cap9,703.75M
  • Shares Out806.37M
  • 10 Day Average Volume8.15M
  • Dividend4.50
  • Dividend Yield0.50%
  • Beta
  • YTD % Change8.62

KEY STATS

  • Open889.30
  • Day High906.75
  • Day Low884.30
  • Prev Close890.90
  • 52 Week High966.35
  • 52 Week High Date04/20/21
  • 52 Week Low565.60
  • 52 Week Low Date05/15/20
  • Market Cap9,703.75M
  • Shares Out806.37M
  • 10 Day Average Volume8.15M
  • Dividend4.50
  • Dividend Yield0.50%
  • Beta
  • YTD % Change8.62

RATIOS/PROFITABILITY

  • EPS (TTM)27.75
  • P/E (TTM)32.38
  • Fwd P/E (NTM)-
  • EBITDA (MRQ)-
  • ROE (MRQ)-
  • Revenue (MRQ)-
  • Gross Margin (MRQ)-
  • Net Margin (MRQ)-
  • Debt To Equity (MRQ)-

EVENTS

  • Earnings Date-
  • Ex Div Date03/19/2020
  • Div Amount1.00
  • Split Date-
  • Split Factor-

Latest On Cipla Ltd

There is no recent news for this security.

Latest From Our Partners

There is no recent news for this security.

Profile

MORE
Cipla Limited is a holding company. The Company is a pharmaceutical company. The Company's strategic business units include Active Pharmaceutical Ingredients (APIs), Respiratory and Cipla Global Access. The Company's geographical segments include India, USA, South Africa and Rest of the World. The Company manufactures metered dose inhalers, dry powder inhalers, nasal sprays, nebulizers and a range of inhaled accessory devices. Cipla Global Access is a tender-based...
Samina Hamied
Vice Chairman
Yusuf Hamied
Non-Executive Chairman
Umang Vohra
Chief Executive Officer
Kedar Upadhye
Chief Financial Officer
Geena Malhotra
Chief Technology Officer
Address
Mumbai Central
Mumbai
400013
India